Literature DB >> 9147650

Pituitary homeobox 2, a novel member of the bicoid-related family of homeobox genes, is a potential regulator of anterior structure formation.

P J Gage1, S A Camper.   

Abstract

Genetic analysis of mouse mutants has demonstrated the importance of the homeobox genes Rpx, Lhx3 and Pit1 for anterior pituitary gland development. Pit1 mutations have also been identified in several human families with multiple pituitary hormone deficiencies. To identify additional homeobox regulators of pituitary development, we screened an adult pituitary gland cDNA library for homeobox sequences. Here, we report the identification of a novel bicoid-related homeodomain gene expressing two alternatively spliced mRNA products, which encode proteins of 271 and 317 amino acids, respectively. The proteins have been named Ptx2a and Ptx2b since they are highly related to Ptx1/P-OTX. Ptx2 is expressed in both developing and adult pituitary gland, eye and brain tissues, suggesting an important role in development and maintenance of anterior structures. Ptx2 was mapped close to Egf on mouse chromosome 3, in a region having extensive synteny homology with HSA 4q. These data make the human Ptx2 homologue a candidate gene for Rieger syndrome, an autosomal-dominant disorder with variable craniofacial, dental, eye and pituitary anomalies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9147650     DOI: 10.1093/hmg/6.3.457

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  51 in total

1.  Pitx2a expression alters actin-myosin cytoskeleton and migration of HeLa cells through Rho GTPase signaling.

Authors:  Qize Wei; Robert S Adelstein
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

Review 2.  Other transcription factors and hypopituitarism.

Authors:  Laurie E Cohen; Sally Radovick
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

3.  Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development.

Authors:  D P Szeto; C Rodriguez-Esteban; A K Ryan; S M O'Connell; F Liu; C Kioussi; A S Gleiberman; J C Izpisúa-Belmonte; M G Rosenfeld
Journal:  Genes Dev       Date:  1999-02-15       Impact factor: 11.361

4.  Expression of Pitx2 in stromal cells is required for normal hematopoiesis.

Authors:  Aurélie Kieusseian; Jalila Chagraoui; Cécile Kerdudo; Philippe-Emmanuel Mangeot; Philip J Gage; Nicole Navarro; Brigitte Izac; Georges Uzan; Bernard G Forget; Anne Dubart-Kupperschmitt
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

5.  Eye formation in the absence of retina.

Authors:  Eric C Swindell; Chaomei Liu; Rina Shah; April N Smith; Richard A Lang; Milan Jamrich
Journal:  Dev Biol       Date:  2008-07-16       Impact factor: 3.582

Review 6.  The role of transcription factor Pitx3 in dopamine neuron development and Parkinson's disease.

Authors:  Jia Li; John A Dani; Weidong Le
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

7.  Distinct transcriptional regulatory mechanisms underlie left-right asymmetric expression of lefty-1 and lefty-2.

Authors:  Y Saijoh; H Adachi; K Mochida; S Ohishi; A Hirao; H Hamada
Journal:  Genes Dev       Date:  1999-02-01       Impact factor: 11.361

8.  Pitx2 deletion in pituitary gonadotropes is compatible with gonadal development, puberty, and fertility.

Authors:  Michael A Charles; Amanda H Mortensen; Mary Anne Potok; Sally A Camper
Journal:  Genesis       Date:  2008-10       Impact factor: 2.487

9.  Targeted Disruption of the Myocilin Gene (Myoc) Suggests that Human Glaucoma-Causing Mutations Are Gain of Function.

Authors:  B S Kim; O V Savinova; M V Reedy; J Martin; Y Lun; L Gan; R S Smith; S I Tomarev; S W John; R L Johnson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

Review 10.  Signaling "cross-talk" is integrated by transcription factors in the development of the anterior segment in the eye.

Authors:  Philip J Gage; Amanda L Zacharias
Journal:  Dev Dyn       Date:  2009-09       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.